Form 4: Coherent Corp. Chief Innovation Officer Executes Stock Transactions Under 10b5-1 Plan

Coherent Corp.'s Chief Innovation Officer, Christopher Koeppen, engaged in multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Summary

• Christopher Koeppen, Chief Innovation Officer of Coherent Corp., executed several transactions involving the company's stock.
• These transactions included the exercise of stock options at prices of $35.25 and $49.90, resulting in the acquisition of 1,740 and 1,380 shares respectively.
• Koeppen also sold a total of 6,176 shares of common stock at various prices ranging from $92.48 to $103.18.
• The sales were conducted under a pre-established Rule 10b5-1 trading plan adopted on June 15, 2023.
• Following these transactions, Koeppen directly owns 63,092 shares of Coherent Corp. stock.
• He also has indirect ownership of shares through his daughter and son, although the exact number of shares is not specified.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy. There is no indication of positive or negative sentiment towards the company's performance.

Positives

• The transactions were part of a pre-planned trading strategy, which can be seen as a responsible approach to managing personal holdings.
• The exercise of options indicates a belief in the company's long-term value.

Negatives

• The sale of a significant number of shares by a high-ranking officer could be interpreted negatively by some investors, although it is part of a pre-planned strategy.

Risks

• The market may react negatively to the sale of shares by a company executive, even if it is part of a pre-planned strategy.
• There is a risk of misinterpretation of the transactions by investors who may not be aware of the 10b5-1 trading plan.

Industry Context

This type of transaction is common for executives of publicly traded companies, especially those with stock-based compensation. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the technology and manufacturing sectors, such as Applied Materials, Lam Research, and ASML.
• These plans allow executives to sell shares without being accused of trading on inside information, aligning with best practices in corporate governance.
• The reported transactions are consistent with typical executive stock sales and option exercises observed in similar companies.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, as the sale of shares by an executive could be perceived negatively, although it is part of a pre-planned strategy.
• The impact on other stakeholders is likely to be minimal.

Key Dates

Keywords

insider trading, stock options, Rule 10b5-1, stock sales, Coherent Corp, Christopher Koeppen, executive compensation, equity transactions